News | Cardiovascular Ultrasound | February 26, 2018

ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound

WASE Normal Values Study will assess whether current recommended normal values for heart dimensions and function are adequate, develop normal values for novel modalities like 3-D and strain

ASE Participating in Global Study to Establish New Standardization in Cardiovascular Ultrasound

February 26, 2018 – The American Society of Echocardiography (ASE) and its International Alliance Partners are joining efforts in the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. This study is bringing together the scientific cardiovascular ultrasound community from around the world to better understand if the current recommended normal values for heart dimensions and function in subjects from different races and countries are similar or different. In addition, normal values for novel echocardiography modalities such as 3-D and strain will be established.

Principal investigators Roberto M. Lang, M.D., FASE, University of Chicago Medical Center, and Federico M. Asch, M.D., FASE, MedStar Health Research Institute in Washington, D.C.,announced that the WASE study has enrolled the landmark number of 1,000 subjects. Asch said, “This represents over 50 percent of our target. We are hoping to complete enrollment by the end of this year. Individuals from six continents have been enrolled and initial preliminary findings will be presented at the ASE 2018 Scientific Sessions in Nashville this June.” Final results are expected to be available in 2019.

The WASE Normal Values Study entails the acquisition of complete 2-D and 3-D echocardiograms in 100 healthy individuals of both genders and across a wide range of ages in each of 17 countries. All echoes will be analyzed in collaboration with MedStar Health and the University of Chicago. The clinical usefulness of echocardiography is based on the detection of abnormalities, which relies on the accurate definition of “normality” across different countries or races. Currently, available echocardiographic “reference values” that define “normality” are mostly based on cross-sectional observations of Caucasians from the U.S. and Europe.

Robin Wiegerink, CEO of ASE said, “This study provides unique opportunities to interact with our global partners to facilitate scientific collaborations and strengthen relationships, with the goal of improved patient care. The ASE International Alliance Partners program was developed to foster this kind of interaction and create synergies that could be replicated in future standardization projects.”

The WASE Normal Values Study is being funded by the American Society of Echocardiography Foundation and its donors, and with in-kind support from sponsors Tomtec Imaging Systems, Medidata, MedStar Health and University of Chicago.

For more information: www.asecho.org

 

Related Content

Image courtesy of Philips Healthcare

News | Clinical Trials | July 19, 2018
The use of computed tomography (CT) scans has increased dramatically over the last two decades. CT scans greatly...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Study Points to Need for Performance Standards for EHR Usability and Safety
News | Electronic Medical Records (EMR) | July 18, 2018
A novel new study provides compelling evidence that the design, development and implementation of electronic health...
Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
Breast Cancer Follow-up Imaging Varies Widely
News | Breast Imaging | July 13, 2018
July 13, 2018 — Follow-up imaging for women...
Siemens Healthineers Launches Acuson Sequoia Ultrasound
Technology | Ultrasound Imaging | July 12, 2018
July 12, 2018 — Siemens Healthineers recently announced the launch of its new ultrasound system, the Acuson Sequoia.
EchoNous Vein Receives FDA Approval to Improve First-Time Peripheral IV Catheter Insertion
Technology | Ultrasound Imaging | July 12, 2018
EchoNous has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EchoNous Vein, an ultrasound-...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Overlay Init